MedPath

Integrated Intervention for Substance Abusers With Depressive Disorders

Phase 2
Completed
Conditions
Substance-Related Disorders
Depressive Disorder
Registration Number
NCT00018655
Lead Sponsor
VA Office of Research and Development
Brief Summary

This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, Twelve Step Facilitation (AA/NA model) group treatment plus medications.

Detailed Description

This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, Twelve Step Facilitation (AA/NA model) group treatment plus medications. Follow-up assessments were conducted at quarterly intervals for one year following treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
276
Inclusion Criteria

Veterans age 18 and older with alcohol, cannabinol, and/or stimulant dependence and independent mood disorders will be included.

Exclusion Criteria

Psychotic disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Hamilton Depression Scale, Timeline Follow-back (substance measure)18 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA San Diego Healthcare System, San Diego

🇺🇸

San Diego, California, United States

VA San Diego Healthcare System, San Diego
🇺🇸San Diego, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.